Papers: 10.1371/journal.pone.0241775

https://doi.org/10.1371/journal.pone.0241775

Rate of reclassification of HER2-equivocal breast cancer cases to HER2-negative per the 2018 ASCO/CAP guidelines and response of HER2-equivocal cases to anti-HER2 therapy

Cited by: 3
Author(s): James Crespo, Hongxia Sun, Jimin Wu, Qing Qing Ding, Guilin Tang, Melissa Robinson, Hui Chen, Ayşegül Şahin, Bora Lim
Published: almost 6 years ago

Software Mentions 1